These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Ogawa K, Yamada Y, Kishibe K, Ishizaki K, Tokusashi Y. Cancer Res; 1999 Apr 15; 59(8):1830-3. PubMed ID: 10213486 [Abstract] [Full Text] [Related]
6. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Hepatology; 2002 Sep 15; 36(3):692-701. PubMed ID: 12198663 [Abstract] [Full Text] [Related]
10. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M. Cancer Res; 2002 Oct 15; 62(20):5685-8. PubMed ID: 12384525 [Abstract] [Full Text] [Related]
13. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. Oncogene; 1999 Aug 19; 18(33):4726-33. PubMed ID: 10467420 [Abstract] [Full Text] [Related]
14. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P. J Pathol; 2003 Oct 19; 201(2):250-9. PubMed ID: 14517842 [Abstract] [Full Text] [Related]
15. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T. Int J Oncol; 2004 May 19; 24(5):1077-83. PubMed ID: 15067328 [Abstract] [Full Text] [Related]
17. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF, Factor VM, Loi R, Thorgeirsson SS. Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770 [Abstract] [Full Text] [Related]
18. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res; 1999 Dec 01; 90(12):inside front cover. PubMed ID: 10665642 [No Abstract] [Full Text] [Related]
19. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E. Oncol Rep; 2006 Mar 01; 15(3):551-6. PubMed ID: 16465411 [Abstract] [Full Text] [Related]
20. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M, Hirohashi S. Hepatology; 2003 Mar 01; 37(3):528-33. PubMed ID: 12601349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]